246 related articles for article (PubMed ID: 22330959)
1. Public health and economic benefits of new pediatric influenza vaccination programs in Argentina.
Giglio N; Gentile A; Lees L; Micone P; Armoni J; Reygrobellet C; Crépey P
Hum Vaccin Immunother; 2012 Mar; 8(3):312-22. PubMed ID: 22330959
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of influenza vaccination in high-risk children in Argentina.
Dayan GH; Nguyen VH; Debbag R; Gómez R; Wood SC
Vaccine; 2001 Jul; 19(30):4204-13. PubMed ID: 11457546
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of influenza vaccination of healthy children.
Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.
Brogan AJ; Talbird SE; Davis AE; Thommes EW; Meier G
Hum Vaccin Immunother; 2017 Mar; 13(3):533-542. PubMed ID: 27780425
[TBL] [Abstract][Full Text] [Related]
8. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives.
de Fougerolles TR; Baïssas T; Perquier G; Vitoux O; Crépey P; Bartelt-Hofer J; Bricout H; Petitjean A
BMC Public Health; 2024 May; 24(1):1222. PubMed ID: 38702667
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluations of childhood influenza vaccination: a critical review.
Newall AT; Jit M; Beutels P
Pharmacoeconomics; 2012 Aug; 30(8):647-60. PubMed ID: 22788257
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI
PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456
[TBL] [Abstract][Full Text] [Related]
11. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.
Baguelin M; Camacho A; Flasche S; Edmunds WJ
BMC Med; 2015 Oct; 13():236. PubMed ID: 26459265
[TBL] [Abstract][Full Text] [Related]
12. Health and economic impact of the seasonal influenza vaccination programme in England.
Baguelin M; Jit M; Miller E; Edmunds WJ
Vaccine; 2012 May; 30(23):3459-62. PubMed ID: 22446636
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis.
Lugnér AK; van Boven M; de Vries R; Postma MJ; Wallinga J
BMJ; 2012 Jul; 345():e4445. PubMed ID: 22791791
[TBL] [Abstract][Full Text] [Related]
14. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children.
Falcón-Lezama JA; Saucedo-Martínez R; Betancourt-Cravioto M; Alfaro-Cortes MM; Bahena-González RI; Tapia-Conyer R
BMC Infect Dis; 2020 Mar; 20(1):240. PubMed ID: 32197591
[TBL] [Abstract][Full Text] [Related]
15. Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model.
Crépey P; Boiron L; Araujo RR; Lopez JG; Petitjean A; de Albuquerque Luna EJ
BMC Public Health; 2020 Sep; 20(1):1374. PubMed ID: 32907562
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
[TBL] [Abstract][Full Text] [Related]
17. Optimising age coverage of seasonal influenza vaccination in England: A mathematical and health economic evaluation.
Hill EM; Petrou S; Forster H; de Lusignan S; Yonova I; Keeling MJ
PLoS Comput Biol; 2020 Oct; 16(10):e1008278. PubMed ID: 33021983
[TBL] [Abstract][Full Text] [Related]
18. School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program.
Basurto-Dávila R; Meltzer MI; Mills DA; Beeler Asay GR; Cho BH; Graitcer SB; Dube NL; Thompson MG; Patel SA; Peasah SK; Ferdinands JM; Gargiullo P; Messonnier M; Shay DK
Health Serv Res; 2017 Dec; 52 Suppl 2(Suppl 2):2307-2330. PubMed ID: 29130266
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
20. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
